Compare Abbott Laboratories (ABT) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Abbott Laboratories trades at $95.37 (market cap $166.94B), while Direxion Daily Semiconductor Bear 3X Shares trades at $4.53. The key difference: Abbott Laboratories pays a 2.63% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none, and Abbott Laboratories is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals.
| ABT | SOXS | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $136.62 | $160.60 |
52-Week Low | $82.57 | $3.25 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
SOXS, the Direxion Daily Semiconductor Bear 3X Shares ETF, is trading at $4.17, down 7.54% over the past 24 hours. The technical outlook is bearish, with moving averages signaling a downtrend and oscillators neutral. A 1-for-10 stock split is scheduled for July 15, 2026. Recent news highlights the ETF's role in betting against the semiconductor sector amid a historic AI-driven chip rally, with SOXS down 88% over six months as of May 2026.
The outlook for SOXS remains highly risky due to its inverse leveraged structure and the strong bullish trend in semiconductors. Investment opportunity exists solely for tactical, short-term traders seeking to profit from potential sector pullbacks, but risks of significant losses are elevated if the rally persists. Long-term investors should avoid due to volatility decay and structural drawbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
